NO950829D0 - Perler med en kjerne belagt med et fungisid og en polymer - Google Patents

Perler med en kjerne belagt med et fungisid og en polymer

Info

Publication number
NO950829D0
NO950829D0 NO950829A NO950829A NO950829D0 NO 950829 D0 NO950829 D0 NO 950829D0 NO 950829 A NO950829 A NO 950829A NO 950829 A NO950829 A NO 950829A NO 950829 D0 NO950829 D0 NO 950829D0
Authority
NO
Norway
Prior art keywords
fungicide
beads
polymer
core coated
coated
Prior art date
Application number
NO950829A
Other languages
English (en)
Other versions
NO950829L (no
NO307953B1 (no
Inventor
Paul M V Gilis
Conde Valentin F V De
Roger P G Vandecruys
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8210890&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO950829(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of NO950829D0 publication Critical patent/NO950829D0/no
Publication of NO950829L publication Critical patent/NO950829L/no
Publication of NO307953B1 publication Critical patent/NO307953B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
NO950829A 1992-09-03 1995-03-02 Perler med en kjerne belagt med et fungicid og en polymer, fremstilling derav, samt doseform inneholdende perlene NO307953B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP92202664 1992-09-03
PCT/EP1993/002327 WO1994005263A1 (en) 1992-09-03 1993-08-27 Beads having a core coated with an antifungal and a polymer

Publications (3)

Publication Number Publication Date
NO950829D0 true NO950829D0 (no) 1995-03-02
NO950829L NO950829L (no) 1995-05-02
NO307953B1 NO307953B1 (no) 2000-06-26

Family

ID=8210890

Family Applications (1)

Application Number Title Priority Date Filing Date
NO950829A NO307953B1 (no) 1992-09-03 1995-03-02 Perler med en kjerne belagt med et fungicid og en polymer, fremstilling derav, samt doseform inneholdende perlene

Country Status (33)

Country Link
US (1) US5633015A (no)
EP (1) EP0658103B1 (no)
JP (1) JP2865869B2 (no)
KR (1) KR0151893B1 (no)
CN (1) CN1034714C (no)
AP (1) AP444A (no)
AT (1) ATE145327T1 (no)
AU (1) AU665867B2 (no)
CA (1) CA2142848C (no)
CY (1) CY2105B1 (no)
CZ (1) CZ283403B6 (no)
DE (1) DE69306119T2 (no)
DK (1) DK0658103T3 (no)
ES (1) ES2097536T3 (no)
FI (1) FI112437B (no)
GR (1) GR3022198T3 (no)
HK (1) HK1006000A1 (no)
HR (1) HRP931158B1 (no)
HU (1) HU220614B1 (no)
IL (1) IL106871A (no)
MX (1) MX9305438A (no)
MY (1) MY109369A (no)
NO (1) NO307953B1 (no)
NZ (1) NZ255379A (no)
OA (1) OA10130A (no)
PH (1) PH30929A (no)
PL (2) PL174178B1 (no)
RU (1) RU2125445C1 (no)
SG (1) SG48801A1 (no)
SI (1) SI9300461B (no)
TW (1) TW376322B (no)
WO (1) WO1994005263A1 (no)
ZA (1) ZA936493B (no)

Families Citing this family (100)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9325445D0 (en) 1993-12-13 1994-02-16 Cortecs Ltd Pharmaceutical formulations
US7008668B2 (en) 1995-05-09 2006-03-07 Phoqus Pharmaceuticals Limited Powder coating composition for electrostatic coating of pharmaceutical substrates
JP4137998B2 (ja) 1995-05-09 2008-08-20 フオカス リミテッド 医薬基材の静電塗装用粉末塗装組成物
US5750147A (en) * 1995-06-07 1998-05-12 Emisphere Technologies, Inc. Method of solubilizing and encapsulating itraconazole
IL124935A (en) * 1996-05-20 2001-06-14 Janssen Pharmaceutica Nv Dissolvable fungicidal preparations contain itraconazole with improved bioavailability
US5846971A (en) * 1996-06-28 1998-12-08 Schering Corporation Oral antifungal composition
KR20000022294A (ko) * 1996-06-28 2000-04-25 둘락 노먼 씨. 트리아졸 항진균 화합물을 함유하는 경구 조성물
GB9623634D0 (en) 1996-11-13 1997-01-08 Bpsi Holdings Inc Method and apparatus for the coating of substrates for pharmaceutical use
FR2758459B1 (fr) * 1997-01-17 1999-05-07 Pharma Pass Composition pharmaceutique de fenofibrate presentant une biodisponibilite elevee et son procede de preparation
PT969821E (pt) * 1997-03-26 2003-10-31 Janssen Pharmaceutica Nv Pastilhas tendo um nucleo revestido com um antifungico e um polimero
KR19990001564A (ko) * 1997-06-16 1999-01-15 유충식 용해도를 개선한 아졸계 항진균제 및 이를 함유하는 제제
KR100514330B1 (ko) * 1997-12-31 2006-02-17 주식회사 중외제약 난용성 약물을 함유하는 코팅정
PT1039909E (pt) * 1997-12-31 2003-02-28 Choongwae Pharma Corp Metodo de producao e composicao de uma preparacao oral de itraconazole
DE19808634A1 (de) * 1998-02-24 1999-08-26 Schering Ag Mantel für eine pharmazeutische Zusammensetzung
UA65607C2 (uk) 1998-03-04 2004-04-15 Орто-Макнейл Фармацевтикал, Інк. Фармацевтична композиція (варіанти) та спосіб її приготування
KR100549095B1 (ko) * 1998-07-17 2006-02-06 얀센 파마슈티카 엔.브이. 항진균제 및 중합체로 코팅된 코어를 갖는 펠릿
ES2157731B1 (es) * 1998-07-21 2002-05-01 Liconsa Liberacion Controlada Preparacion farmaceutica oral de un compuesto de actividad antifungica y procedimiento para su preparacion.
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
IL145140A0 (en) 1999-03-24 2002-06-30 Fmc Corp Improved aqueous solubility pharmaceutical formulations
US20030236236A1 (en) * 1999-06-30 2003-12-25 Feng-Jing Chen Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
US20060034937A1 (en) * 1999-11-23 2006-02-16 Mahesh Patel Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
US20030180352A1 (en) * 1999-11-23 2003-09-25 Patel Mahesh V. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
KR100694667B1 (ko) * 1999-12-08 2007-03-14 동아제약주식회사 생체내이용률 향상과 개인간 및 개인내 흡수 편차를감소시킨 이트라코나졸 함유 항진균성 제제
AU2331801A (en) * 1999-12-23 2001-07-09 F.H. Faulding & Co. Limited Improved pharmaceutical compositions for poorly soluble drugs
CN102772413A (zh) * 2000-02-29 2012-11-14 布里斯托尔-迈尔斯斯奎布公司 低剂量艾替开韦制剂及其应用
US6551608B2 (en) * 2000-03-06 2003-04-22 Porex Technologies Corporation Porous plastic media with antiviral or antimicrobial properties and processes for making the same
US6977085B2 (en) * 2000-12-22 2005-12-20 Baxter International Inc. Method for preparing submicron suspensions with polymorph control
US6673373B2 (en) 2001-02-01 2004-01-06 Carlsbad Technology Inc. Antifungal formulation and the methods for manufacturing and using the same
US6663897B2 (en) 2001-02-06 2003-12-16 Dsm Ip Assets B.V. Oral itraconazole formulations and methods of making the same
AU2002302363B2 (en) 2001-02-14 2008-05-01 Tibotec Pharmaceuticals Ltd. Broadspectrum 2-(substituted-amino)-benzothiazole sulfonamide HIV protease inhibitors
OA12464A (en) 2001-04-09 2006-05-24 Tibotec Pharm Ltd Broadspectrum 2-(substituted-amino)-benzoxazole sulfonamide HIV protease inhibitors.
PT1387842E (pt) 2001-05-11 2009-07-20 Tibotec Pharm Ltd 2-aminobenzoxazolsulfonamidas inibidoras de largo espectro da protease hiv
AU4061702A (en) * 2001-05-15 2003-04-03 Mcneil-Ppc, Inc. Dip coating compositions containing starch or dextrin
US20030070584A1 (en) * 2001-05-15 2003-04-17 Cynthia Gulian Dip coating compositions containing cellulose ethers
KR100438485B1 (ko) * 2001-08-13 2004-07-09 한국디디에스제약 주식회사 아졸류 항진균제의 약제학적 조성물
US8071133B2 (en) 2001-08-20 2011-12-06 Stiefel Laboratories, Inc. Oral dosage forms of water insoluble drugs and methods of making the same
US8309118B2 (en) * 2001-09-28 2012-11-13 Mcneil-Ppc, Inc. Film forming compositions containing sucralose
CA2363376A1 (en) * 2001-11-16 2003-05-16 Bernard Charles Sherman Solid pharmaceutical compositions for oral administration comprising itraconazole
TWI336621B (en) 2001-12-21 2011-02-01 Tibotec Pharm Ltd Broad spectrum heterocyclic substituted phenyl containing sulfonamide hiv protease inhibitors
US7927613B2 (en) 2002-02-15 2011-04-19 University Of South Florida Pharmaceutical co-crystal compositions
US20030224006A1 (en) 2002-03-01 2003-12-04 Zaworotko Michael J. Multiple-component solid phases containing at least one active pharmaceutical ingredient
WO2003101392A2 (en) * 2002-05-31 2003-12-11 Transform Pharmaceuticals, Inc. Novel conazole crystalline forms and related processes, pharmaceutical compositions and methods
US20100311701A1 (en) * 2002-02-15 2010-12-09 Transform Pharmaceuticals, Inc Pharmaceutical Co-Crystal Compositions
US7790905B2 (en) * 2002-02-15 2010-09-07 Mcneil-Ppc, Inc. Pharmaceutical propylene glycol solvate compositions
US7446107B2 (en) * 2002-02-15 2008-11-04 Transform Pharmaceuticals, Inc. Crystalline forms of conazoles and methods of making and using the same
MY142238A (en) 2002-03-12 2010-11-15 Tibotec Pharm Ltd Broadspectrum substituted benzimidazole sulfonamide hiv protease inhibitors
DE60315984T2 (de) 2002-05-17 2008-05-29 Tibotec Pharmaceuticals Ltd. Substituierte benzisoxazolsulfonamide mit breitbändiger hiv-protease hemmender wirkung
US20070059356A1 (en) * 2002-05-31 2007-03-15 Almarsson Oern Pharmaceutical co-crystal compositions of drugs such as carbamazepine, celecoxib, olanzapine, itraconazole, topiramate, modafinil, 5-fluorouracil, hydrochlorothiazide, acetaminophen, aspirin, flurbiprofen, phenytoin and ibuprofen
AU2003243699B2 (en) * 2002-06-21 2009-01-15 Transform Pharmaceuticals, Inc. Pharmaceutical compositions with improved dissolution
EP1542728A4 (en) * 2002-07-22 2005-09-21 Nanohybrid Co Ltd HYBRID OF ITRACONAZOLE, CYCLOSPORINE OR CARVEDILOL WITH A LAYERED SILICATE AND PROCESS FOR PREPARING THE SAME
US7429619B2 (en) * 2002-08-02 2008-09-30 Mcneil Consumer Healthcare Polyacrylic film forming compositions
AU2003262574B2 (en) 2002-08-14 2009-07-09 Tibotec Pharmaceuticals Ltd. Broadspectrum substituted oxindole sulfonamide HIV protease inhibitors
US20040086567A1 (en) * 2002-10-30 2004-05-06 Pawan Seth Bioequivalent composition of itraconazole and a hydrophilic polymer
WO2004047778A1 (en) 2002-11-26 2004-06-10 Uc Tech Materials and methods for preventing and treating microbe-mediated epithelial disorders
US8183290B2 (en) 2002-12-30 2012-05-22 Mcneil-Ppc, Inc. Pharmaceutically acceptable propylene glycol solvate of naproxen
SI1438961T2 (sl) * 2003-01-14 2014-12-31 Cimex Pharma Ag Bioekvivalenten sestavek itrakonazola, dispergiranega v hidrofilnem polimeru
DK1438960T4 (da) * 2003-01-14 2013-03-25 Cimex Pharma Ag Sammensætning af itraconazol dispergeret i en hydrofil polymer med forhøjet biotilgængelighed
FR2852607B1 (fr) * 2003-03-20 2006-07-14 Procede de fabrication de microspheres de sucre de petite taille, les microspheres susceptibles d'etre obtenues par ce procede et leurs applications
UA84020C2 (ru) 2003-09-11 2008-09-10 Тиботек Фармасьютикелз Лтд. Ингибитор проникновения вируса вил
US20050074494A1 (en) * 2003-10-06 2005-04-07 Xiu-Xiu Cheng Itraconazole immediate release formulation
US20050118265A1 (en) * 2003-11-28 2005-06-02 Anandi Krishnan Antifungal oral dosage forms and the methods for preparation
US9247765B2 (en) 2004-01-14 2016-02-02 Omniactive Health Technologies Limited Stable beadlets of lipophilic nutrients
JP2007526341A (ja) * 2004-03-03 2007-09-13 スフェリックス， インコーポレイテッド 疎水性薬物のためのポリマー薬物送達システム
AR048650A1 (es) 2004-05-04 2006-05-10 Tibotec Pharm Ltd Derivados de (1,10b-dihidro-2-(aminocarbonil-fenil)-5h-pirazolo[1,5 c][1,3]benzoxazin-5-il)fenil metanona como inhibidores de la replicacion viral del vih
EP1750696B1 (en) 2004-05-07 2013-06-26 Sequoia Pharmaceuticals Inc RETROVIRAL PROTEASE INHIBITORS RESISTING THEIR RESISTANCE
AP2006003791A0 (en) 2004-05-17 2006-10-31 Tibotec Pharm Ltd 1-Heterocyclyl-1,5-dihydro-pyridoÄ3,2-BÜindol-2-ones
WO2005111044A1 (en) 2004-05-17 2005-11-24 Tibotec Pharmaceuticals Ltd. 4-substituted-1,5-dihydro-pyrido[3,2-b]indol-2-ones
AR049637A1 (es) 2004-05-17 2006-08-23 Tibotec Pharm Ltd 1-fenil-1,5-dihidro-pirido[3,2-b]indol-2-onas sustituidas en las posiciones 6, 7, 8, 9
WO2006026504A2 (en) * 2004-08-27 2006-03-09 Spherics, Inc. Mucoadhesive oral formulations of high permeability, high solubility drugs
US20060045865A1 (en) * 2004-08-27 2006-03-02 Spherics, Inc. Controlled regional oral delivery
US20060045822A1 (en) * 2004-09-01 2006-03-02 Board Of Regents, The University Of Texas System Plasma polymerization for encapsulating particles
US20100297248A1 (en) * 2004-09-01 2010-11-25 Board Of Regents, The University Of Texas System Encapsulated particles for amorphous stability enhancement
FR2883179B1 (fr) 2005-03-18 2009-04-17 Ethypharm Sa Comprime enrobe
AR056652A1 (es) 2005-04-11 2007-10-17 Tibotec Pharm Ltd Derivados de (1,10-b dihidro-2-(aminoalquil-fenil) -5h-pirazolo (1,5-c) (1,3)benzoxazin-5-il) fenilmetanona y su uso en la fabricacion de un medicamento
US20090118721A1 (en) * 2005-07-21 2009-05-07 Eric Bornstein Near Infrared Microbial Elimination Laser System (NIMELS)
US20070148240A1 (en) * 2005-12-23 2007-06-28 Fang-Yu Lee Oral formulation containing itraconazole and methods for manufacturing and using the same
BRPI0709940A2 (pt) 2006-04-03 2011-08-02 Tibotec Pharm Ltd 3,4-diidro-imidazo[4,5-b]piridin-5-onas para inibição do hiv
CN101091725A (zh) * 2006-06-23 2007-12-26 天津天士力制药股份有限公司 一种中药颗粒及其制备方法
WO2008110534A1 (en) * 2007-03-13 2008-09-18 Sandoz Ag Pharmaceutical compositions of poorly soluble drugs
CN101283984B (zh) * 2007-04-12 2010-05-26 永胜药品工业股份有限公司 高生物使用率的经杀真菌剂和聚合物涂覆的核心微粒状物
US7314641B1 (en) 2007-04-18 2008-01-01 Everest Pharm. Industrial Co., Ltd. High-bioavailability particle coated with fungicide and polymer
JP2008280254A (ja) * 2007-05-08 2008-11-20 Everest Pharm Industrial Co Ltd 生体に使用される比率が高い、殺菌剤と重合物を塗粧してる核心微粒状物
CA2707161C (en) 2007-11-28 2016-08-16 Sequoia Pharmaceuticals, Inc. Compositions and methods for inhibiting cytochrome p450 2d6
CA2716348C (en) 2008-02-21 2017-04-04 Sequoia Pharmaceuticals, Inc. Diamide inhibitors of cytochrome p450
WO2009114834A2 (en) 2008-03-13 2009-09-17 Board Of Regents, The University Of Texas System Covalently functionalized particles for synthesis of new composite materials
US11304960B2 (en) 2009-01-08 2022-04-19 Chandrashekar Giliyar Steroidal compositions
SG174658A1 (en) 2010-04-01 2011-10-28 Theravida Inc Pharmaceutical formulations for the treatment of overactive bladder
WO2011146078A1 (en) * 2010-05-21 2011-11-24 Board Of Regents, The University Of Texas System Encapsulated particles for enteric release
US9034858B2 (en) 2010-11-30 2015-05-19 Lipocine Inc. High-strength testosterone undecanoate compositions
US20180153904A1 (en) 2010-11-30 2018-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US9358241B2 (en) 2010-11-30 2016-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US20120148675A1 (en) 2010-12-10 2012-06-14 Basawaraj Chickmath Testosterone undecanoate compositions
ES2565353T3 (es) * 2010-12-16 2016-04-04 Borje S. Andersson Formulaciones farmacéuticas de azol para administración parenteral y métodos para la preparación y el uso de las mismas como tratamiento de enfermedades sensibles a los compuestos de azol
CA2835277A1 (en) 2011-05-10 2012-11-15 Theravida, Inc. Combinations of solifenacin and salivary stimulants for the treatment of overactive bladder
BR112014031706A8 (pt) 2012-06-21 2021-10-19 Mayne Pharma Int Pty Ltd Composições farmacêuticas orais, e composição farmacêutica oral compreendendo itraconazol
CN103948911B (zh) * 2014-04-23 2016-04-20 深圳市健元医药科技有限公司 一种棘白菌素类抗真菌药物缓释微球制剂及其制备方法
US9498485B2 (en) 2014-08-28 2016-11-22 Lipocine Inc. Bioavailable solid state (17-β)-hydroxy-4-androsten-3-one esters
US20170246187A1 (en) 2014-08-28 2017-08-31 Lipocine Inc. (17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE
BR112018014661A2 (pt) 2016-01-20 2018-12-11 Theravida Inc composição e composição para uso
WO2018098501A1 (en) 2016-11-28 2018-05-31 Lipocine Inc. Oral testosterone undecanoate therapy

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4916134A (en) * 1987-03-25 1990-04-10 Janssen Pharmacuetica N.V. 4-[4-[4-[4-[[2-(2,4-difluorophenyl)-2-(1H-azolylmethyl)-1,3-dioxolan-4-yl]me]phenyl]-1-piperazinyl]phenyl]triazolones
NZ223799A (en) * 1987-03-25 1989-12-21 Janssen Pharmaceutica Nv Azolylmethyl-dioxolanylmethoxyphenyl-piperazinyl-phenyl-triazolones and antimicrobial compositions
US4855326A (en) * 1987-04-20 1989-08-08 Fuisz Pharmaceutical Ltd. Rapidly dissoluble medicinal dosage unit and method of manufacture
JPH01165520A (ja) * 1987-12-23 1989-06-29 Shin Etsu Chem Co Ltd 持続性製剤およびその製造方法
US5049374A (en) * 1989-11-28 1991-09-17 Dansereau Richard J Oral (coated bead) dosage form for sodium iodide I-131
US5213811A (en) * 1991-09-13 1993-05-25 Sterling Drug Inc. Oral sustained-release drug compositions

Also Published As

Publication number Publication date
CN1088432A (zh) 1994-06-29
HRP931158B1 (en) 1999-02-28
RU2125445C1 (ru) 1999-01-27
NO950829L (no) 1995-05-02
TW376322B (en) 1999-12-11
CZ283403B6 (cs) 1998-04-15
AP9300563A0 (en) 1993-10-31
SI9300461A (en) 1994-03-31
NZ255379A (en) 1996-06-25
GR3022198T3 (en) 1997-03-31
MX9305438A (es) 1994-03-31
SI9300461B (en) 2001-12-31
DE69306119D1 (de) 1997-01-02
IL106871A (en) 1998-02-22
NO307953B1 (no) 2000-06-26
ES2097536T3 (es) 1997-04-01
ZA936493B (en) 1995-03-02
EP0658103B1 (en) 1996-11-20
HRP931158A2 (en) 1995-06-30
HUT70419A (en) 1995-10-30
ATE145327T1 (de) 1996-12-15
HU9500642D0 (en) 1995-04-28
PL172676B1 (pl) 1997-11-28
SG48801A1 (en) 1998-05-18
HK1006000A1 (en) 1999-02-05
CY2105B1 (en) 2002-04-26
JP2865869B2 (ja) 1999-03-08
JPH08501092A (ja) 1996-02-06
IL106871A0 (en) 1993-12-28
CN1034714C (zh) 1997-04-30
AP444A (en) 1996-01-19
HU220614B1 (hu) 2002-03-28
MY109369A (en) 1997-01-31
FI950975A0 (fi) 1995-03-02
CA2142848A1 (en) 1994-03-17
FI950975A (fi) 1995-03-02
PH30929A (en) 1997-12-23
CZ54295A3 (en) 1995-09-13
DE69306119T2 (de) 1997-03-13
WO1994005263A1 (en) 1994-03-17
KR0151893B1 (ko) 1998-10-15
OA10130A (en) 1996-12-18
US5633015A (en) 1997-05-27
PL174178B1 (pl) 1998-06-30
AU665867B2 (en) 1996-01-18
AU4954693A (en) 1994-03-29
EP0658103A1 (en) 1995-06-21
PL307791A1 (en) 1995-06-26
FI112437B (fi) 2003-12-15
DK0658103T3 (da) 1996-12-09
CA2142848C (en) 1999-11-16

Similar Documents

Publication Publication Date Title
NO950829L (no) Perler med en kjerne belagt med et fungisid og en polymer
DE69508846D1 (de) Absorbierender Artikel mit einem körperanpassungsfähigen Absorptionskern
DE4493840T1 (de) Katheteranordnung mit einem Katheter
DE69304973D1 (de) Beschichtete Aufzeichnungsblätter
DE69324300T2 (de) Deaktivierbares/reaktivierbares magnetisches Etikett mit einem Stufenwechsel in magnetischem Fluss
DE69333565D1 (de) Dilatationskatheter mit geringem Querschnitt
DE69419506T2 (de) Mehrfach zu verwendender klebebandverschluss
DE69317598T2 (de) Magnetresistiver Wandler
ATA147093A (de) Scharnier mit drehtopf
DE69415013D1 (de) Orthopädischer steifverbandartikel mit leicht zu öffnender verpackung
ITMI920335V0 (it) Scaletta a palchetto carrellata e scomponibile
NO934010L (no) Plastbelagt bladhengsel
KR960015398U (ko) 테이프와 통이 돌아가는 암기통
ITLE940009A0 (it) Birotore a re4pulsione magnetica
FI932485A0 (fi) Ytelement och saett att faesta det
DK110892D0 (da) Et vindstop
IT233932Y1 (it) Album fotografico con veline a vincolo rafforzato e visivamente occultato
IT230769Y1 (it) Etichette richiudibili a lunga durata
DE9316718U1 (de) Kernstütze mit Einschießzapfen
DE9320876U1 (de) Bandwickler
GB9312616D0 (en) A voice and data network
KR940025695U (ko) 페라이트 코어
KR940022059U (ko) 자석 테이프

Legal Events

Date Code Title Description
MK1K Patent expired